Immune checkpoint inhibitor (physician's choice)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Immune checkpoint inhibitor (physician's choice), covering 2025-09-26 to 2025-09-26. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer [Phase 2]